|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 31/04 | |||
| C07K 16/12 |
| (11) | Number of the document | 2945651 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14703783.2 |
| Date of filing the European patent application | 2014-01-17 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/050895 |
| Date | 2014-01-17 |
| (87) | Number | WO 2014/111516 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 13151627 | 2013-01-17 | EP |
| (72) |
NAGY, Eszter, AT
NAGY, Gįbor, HU
SZIJ RTO, Valéria, AT
MAGYARICS, Zoltįn, AT
MIRKINA, Irina, AT
GUACHALLA, Luis, AT
BADARAU, Adriana, AT
ZAUNER, Gerhild, AT
LUKASIEWICZ, Jolanta, PL
|
| (73) |
ARSANIS Biosciences GmbH,
Helmut-Qualtinger-Gasse 2, 1030 Vienna,
AT
|
| (54) | MDR E. COLI SPECIFIC ANTIBODY |
| MDR E. COLI SPECIFIC ANTIBODY |